NCT01100502 · Interventional trial
A Phase 3 Study of Brentuximab Vedotin (SGN-35) in Patients at High Risk of Residual Hodgkin Lymphoma Following Stem Cell Transplant (The AETHERA Trial)
Overall registry status Completed
Phase 3
Conditions Disease, Hodgkin
Delaware Valley sites
- Temple Bone Marrow Transplant Program · Philadelphia, PA · Philadelphia County
First posted
Registry updated
Added to the directory